NCT06496087View on ClinicalTrials.gov

Evaluation of DEPREXIL in Patients With Clinical Depression Through Psychological and Neuroendocrine Assessment

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

April 15, 2024

Conditions
DepressionPost-COVID-19 SyndromeDepression MildDepression Moderate
Interventions
DIETARY_SUPPLEMENT

DEPREXIL

The trial group will be administered 1 capsule of DEPREXIL orally every 8 hours for 6 months of treatment.

Trial Locations (1)

110131

Fundación CR INVESTIGATION INSTITUTE, Bogotá

All Listed Sponsors
lead

Catalysis SL

INDUSTRY